Back to news archive
New clinical study to evaluate QuickMIC® in the diagnostic workflow of urosepsis
Today we announce the start of a new QuickMIC® study in collaboration with Assoc. Prof. Martin Sundqvist at Örebro University Hospital. The study will investigate the clinical utility of a new rapid workflow for prediction of optimal antibiotic treatment for patients with urosepsis.
Urinary tract infections that causes sepsis is a challenging problem in hospitals today, where early targeted treatment and the use of AST results from urine culture potentially can reduce broad-spectrum antibiotics and their associated adverse effects, and the length of hospitalisation.